Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10941013 | Immunobiology | 2013 | 8 Pages |
Abstract
These results taken together with earlier studies on systemic administration of p38 MAPK inhibitors in rodents and humans suggest that direct intrapulmonary delivery of a p38 MAPK inhibitor is less effective in inhibiting inflammation and is associated with unexpected procoagulant effects in the bronchoalveolar space.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Arie Johan Hoogendijk, Sandra Sofia Pinhanços, Tom van der Poll, Catharina Wilhelmina Wieland,